Jubilant Pharmova Limited (NSE:JUBLPHARMA)
India
· Delayed Price · Currency is INR 995.80
+6.50 (0.66%)
May 21, 2025, 2:30 PM IST
Jubilant Pharmova Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Operating Revenue | 71,921 | 67,029 | 62,817 | 61,302 | 60,985 | Upgrade
|
| Other Revenue | 992 | - | - | - | - | Upgrade
|
| Revenue | 72,913 | 67,029 | 62,817 | 61,302 | 60,985 | Upgrade
|
| Revenue Growth (YoY) | 8.78% | 6.71% | 2.47% | 0.52% | 2.05% | Upgrade
|
| Cost of Revenue | 23,170 | 23,513 | 20,816 | 14,880 | 15,360 | Upgrade
|
| Gross Profit | 49,743 | 43,516 | 42,001 | 46,422 | 45,625 | Upgrade
|
| Selling, General & Admin | 22,679 | 22,873 | 22,151 | 20,739 | 19,440 | Upgrade
|
| Other Operating Expenses | 14,759 | 11,593 | 12,011 | 13,621 | 11,509 | Upgrade
|
| Operating Expenses | 41,124 | 38,285 | 38,252 | 38,023 | 34,183 | Upgrade
|
| Operating Income | 8,619 | 5,231 | 3,749 | 8,398 | 11,443 | Upgrade
|
| Interest Expense | -2,403 | -2,564 | -1,686 | -1,382 | -1,734 | Upgrade
|
| Interest & Investment Income | - | 261 | 98 | 24.51 | 80.97 | Upgrade
|
| Earnings From Equity Investments | -5 | 511 | 123 | -99.83 | 112.52 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -42 | 172 | -464.53 | -644.67 | Upgrade
|
| Other Non Operating Income (Expenses) | - | -5 | -83 | 14.45 | -40.22 | Upgrade
|
| EBT Excluding Unusual Items | 6,211 | 3,392 | 2,373 | 6,491 | 9,218 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 2 | -50 | 1.47 | 28.23 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -27 | -33.7 | -66.91 | Upgrade
|
| Asset Writedown | - | -1,689 | -1,450 | -153.83 | -255.81 | Upgrade
|
| Other Unusual Items | 3,595 | - | -568 | - | -212.31 | Upgrade
|
| Pretax Income | 9,806 | 1,705 | 278 | 6,304 | 8,711 | Upgrade
|
| Income Tax Expense | 1,443 | 978 | 927 | 2,174 | 2,972 | Upgrade
|
| Earnings From Continuing Operations | 8,363 | 727 | -649 | 4,130 | 5,739 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | 2,618 | Upgrade
|
| Net Income to Company | 8,363 | 727 | -649 | 4,130 | 8,356 | Upgrade
|
| Minority Interest in Earnings | 31 | 44 | 39 | 9.2 | 2.58 | Upgrade
|
| Net Income | 8,394 | 771 | -610 | 4,139 | 8,359 | Upgrade
|
| Net Income to Common | 8,394 | 771 | -610 | 4,139 | 8,359 | Upgrade
|
| Net Income Growth | 988.72% | - | - | -50.48% | -6.94% | Upgrade
|
| Shares Outstanding (Basic) | 158 | 159 | 159 | 159 | 159 | Upgrade
|
| Shares Outstanding (Diluted) | 159 | 159 | 159 | 159 | 159 | Upgrade
|
| Shares Change (YoY) | -0.02% | -0.18% | -0.02% | -0.06% | -0.01% | Upgrade
|
| EPS (Basic) | 52.99 | 4.86 | -3.83 | 26.01 | 52.48 | Upgrade
|
| EPS (Diluted) | 52.85 | 4.86 | -3.83 | 26.00 | 52.48 | Upgrade
|
| EPS Growth | 987.45% | - | - | -50.46% | -6.93% | Upgrade
|
| Free Cash Flow | -435 | 736 | -1,538 | 2,376 | 12,568 | Upgrade
|
| Free Cash Flow Per Share | -2.74 | 4.63 | -9.66 | 14.92 | 78.91 | Upgrade
|
| Dividend Per Share | - | 5.000 | 5.000 | 5.000 | 5.000 | Upgrade
|
| Gross Margin | 68.22% | 64.92% | 66.86% | 75.73% | 74.81% | Upgrade
|
| Operating Margin | 11.82% | 7.80% | 5.97% | 13.70% | 18.76% | Upgrade
|
| Profit Margin | 11.51% | 1.15% | -0.97% | 6.75% | 13.71% | Upgrade
|
| Free Cash Flow Margin | -0.60% | 1.10% | -2.45% | 3.88% | 20.61% | Upgrade
|
| EBITDA | 12,305 | 7,933 | 6,463 | 10,663 | 14,676 | Upgrade
|
| EBITDA Margin | 16.88% | 11.83% | 10.29% | 17.39% | 24.07% | Upgrade
|
| D&A For EBITDA | 3,686 | 2,702 | 2,714 | 2,264 | 3,234 | Upgrade
|
| EBIT | 8,619 | 5,231 | 3,749 | 8,398 | 11,443 | Upgrade
|
| EBIT Margin | 11.82% | 7.80% | 5.97% | 13.70% | 18.76% | Upgrade
|
| Effective Tax Rate | 14.71% | 57.36% | 333.45% | 34.49% | 34.12% | Upgrade
|
| Revenue as Reported | 72,913 | 67,716 | 63,200 | 61,415 | 61,162 | Upgrade
|
| Advertising Expenses | - | 664 | 413 | 259.84 | 161.77 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.